Get the app
US › Healthcare

Genprex Inc (GNPX)

US · Healthcare · Biotechnology

$2.11-7.86%
Last close · 2026-10-16

Latest quarter · ended 2026-06-30

Revenue
$0
Net profit
$-4.4M
EPS
$-9.40

Key statistics

Market cap
$2.2M
Forward P/E
0.0
P/B
0.21
Book value
$29.23
EPS (TTM)
$-9.35
52-week high
$1,210.00
52-week low
$2.53
50-day MA
$3.67
200-day MA
$23.60
Beta
-0.97

Analyst view

with an average price target of $7.50.

Shareholding

Insiders
0.21%
Institutions
1.73%

Largest institutional holders

FundStake
Vanguard Fiduciary Trust Co0.43%
HRT FINANCIAL LLC0.40%
Geode Capital Management, LLC0.33%
Vanguard Capital Management, LLC0.20%
Mayflower Financial Advisors, LLC0.11%
UBS Group AG0.02%
Cheviot Value Management, Inc.0.01%
BlackRock Inc0.00%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Genprex Inc — free to start.

Open in the appGoogle PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncUnitedHealth Group IncorporatedMerck & Company IncNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncAmgen IncGilead Sciences IncAbbott LaboratoriesNovo Nordisk A/S

Data updated 2026-10-18.